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concentrations (p<0.01). In contrast, the intracellular ino-
sitol concentration remai ned unchanged (0.156 ± 0.012 f-tg 
106 cells-1 vs 0.133±0.015 f-tg 106 cells-1). Inositol transport 
rates and Na + /K + ATPase activity were also unaffected by 
changes in intracellular sorbitol concentrations: Inositol 
transport V max 5.10±0.89 pmol min-1106 cells-1 vs 5.34± 
0.88 pmol min-1106 cells-1; K m 41.0±5.2 f-tM vs 48.6±5.4 f-tM): 
Na+/K+ATPase activity (Rb86 assay) 35.2±7.2 vs 34.7±5.0 
DPM min-1106 cells- 1. 
These results clearly demonstrate that changes in the 
intracellular sorbitol concentration do not exert direct effects 
on intracellular inositol concentration, inositol transport 
rates or Na+ /K+ ATPase activity. These observations have 
important implications for the polyol theory. 
P36. Ascorbic acid depletion in patients with 
Type 2 diabetes consuming adequate dietary 
vitamin C. 
Sinclair A. J., Taylor P. B. University of Wales College 
of Medicine, Cardiff and Department of Nutrition and 
lJip.tetics, Selly Oak Hospital, Birmingham. 
Disturbances of vitamin C (ascorbic acid, AA) metabolism 
in diabetes have been frequently reported, and although free 
radical mechanisms have been linked to this phenomenon, 
the exact underlying mechanism is unknown. Since dietary 
inadequacy of vitamin C may be a potential factor in diabetic 
patients, we measured vitamin C intake, using a 4 day food 
diary and vitamin C questionnaire, in a group of 30 age-
matched healthy controls (age 68.8±6.9i 17 M/13 F) and in 
a group of 30 age-matched healthy controls (age 68.0±5.5i 
12 M/18 F). In addition, venous blood samples were taken 
. for measurement of plasma M, dehydroascorbic acid (DHA), 
glucose and fructosamine in 20 subjects in each group. 
Plasma concentrations of AA and DHA were significantly 
lower in patients than in controls, M: 29.1 ± 19.2 vs 
68.8 ± 36.0, P < 0.0001 i DHA: 27.5 ± 6.6 vs 31.8 ± 4.8, P < 0.01. 
No significant differences in AA intake were seen between 
the groups using either method: 1.4 day diary: 61 ±28 
(patients) vs 69±33 (controls) mg day-1i 2. questionnaire: 
54±29 (patients) vs 65±31 (controls). Plasma AA and mean 
dietary AA intake over 4 days was significantly correlated: 
r=0.49, p<0.01. 
In conclusion, 1. Diabetes is associated with a marked 
reduction in plasma AAi 2. M depletion appears to be a 
direct consequence of the diabetic process rather than due 
to inadequate dietary AA intakei 3. AA supplementation of 
the diet in diabetes may be necessary to maintain satisfactory 
vitamin C status. 
P37. A comparison of pancreatic ductal and 
interstitial collagenase injection in porcine islet 
isolation. 
Heald K. A., Jay T., Downing R. Department of General 
Surgery, Worcester Royal Infirmary, Worcester. 
The most efficient method of islet isolation in many 
mammalian species results from injection of collagenase into 
the pancreatic duct. In this study, the effect of interstitial 
and intraductal injections of collagenase on the isolation of 
porcine islets has been assessed. 
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Pancreata obtained from a slaughterhouse were transected: 
The duct of one half was cannulated and the gland distended 
with collagenase (A)i collagenase was injected in the other 
half at multiple sites (B). The islet isolation procedures 
thereafter were identical. Islets yields were determined by 
counting dithizone stained cell clusters. 
The numbers of islets isolated by each method were 
not significantly different: 17867 ± 6373 per g pancreas 
(mean±SD) (A) and 21733±8065 per g pancreas (B) (p>0.2: 
n = 7). The number of islet equivalents, assuming a standard 
islet diameter of 150f-tm, was 2423±795 (A) and 2797±1149 
(B). However, 10% of islets isolated using intraductal 
collagenase were 100-200 f-tm diameter, whereas only 3% of 
islets obtained after multiple injection of collagenase were 
in this size range. Islets from both groups increased insulin 
secretion in response to glucose stimulation in vitro. 
I n conclusion, injection of collagenase into the pancreatic 
duct system does not result in greater yields of porcine islets 
than injection of the enzyme at multiple sites throughout 
the gland. 
P38. Variability of the rate of absorption of 
soluble insulin and resulting hypoglycaemic 
effect: influence of injection site. 
Vora J., Burch A., Peters J. R., Owens D. R. Depart-
ment of Medicine, University of Wales College of 
Medicine, Cardiff. 
The variability in the absorption of 12sl-soluble insulin and 
its hypoglycaemic effect over 6 h were compared for the 
abdominal wall, thigh and upper arm regions in 6 normals 
(age: 23-27 yri Body Mass Index: 18.2-24.1 kg m-2). Each site 
was assessed on two separate occasions, in a randomized 
order. Absorption of 6 U 1251-soluble insulin, including 
during the early lag-phase of slow absorption, was deter-
mined using 2 and 3 parameter biexponential models' 
description of residual radioactivity at injection sites-time 
curves, and plasma insulin levels. Absorption of soluble 
insulin was significantly faster with shorter duration lag-
phase and earlier maximal hypoglycaemic effect for the 
abdominal site compared with the thigh and arm 
(p < 0.05-0.001), with no significant differences between the 
latter two sites. Within- (CVw) and between-subject (CVb) 
coefficients of variation for insulin absorption rate-constants 
of 15-29% and 23-38% were similar for the three sites, as 
were CVw and CVb for the lag-phase parameters at 5-20% 
and 20-40% respectively. CVw for plasma glucose levels 
over the 6 h period ranged between 5-20% for the three sites, 
whilst CVb increased gradually from 5-10% prior to soluble 
insulin to 22-28%, coinciding with plasma glucose nadirs. 
Thus, despite regional differences in the rate of absorption 
of soluble insulin, within- and between-subject variability 
in its absorption and hypoglycaemic effect are of similar 
magnitude for the three sites. 
P39. Vanadate lowers blood glucose in 
diabetic rats by suppressing food intake: 
absence of a specific anti-diabetic action. 
Malabu U. H., Ware M. A., Kilpatrick A. M., Dryden 5., 
McCarthy H. D., Williams G. Department of Medicine, 
University of Liverpool. 
Vanadate mimics insulin action in vitro, lowers blood 
glucose in diabetic rats, and has been suggested as a novel 
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treatment for diabetes. However, it also inhibits feeding which 
itself could lower blood glucose. We assessed the contribution 
of hypophagia to vanadate's anti-hyperglycaemic action in 
a 3-week study of streptozotocin-diabetic (STZ-DM) rats. 
Untreated diabetics (n =8) ate significantly more than 
non-diabetic controls (n=8; food intake, 68±3 (SEM) vs 
44±1 g rat- 1 day-1, p<0.001). Diabetic rats (n=8) given 
sodium metavanadate (0.5 mg in 0.5 ml water by gavage 
twice-daily after diabetes induction) had significantly lower 
food intakes (41 ±2 g rat- 1 day- 1, p < 0.001) than untreated 
diabetics. Vanadate-treated diabetic rats had significantly 
lower blood glucose levels (average after 5 days, 16.5± 
3.0 mmoll- 1) than untreated diabetics (38.2±3.4 mmoll - 1, 
p < 0.001). However, diabetic rats (n =8), not given vana-
date but restricted to the food intake of the vanadate-
treated diabetics, showed virtually identical blood glu-
cose falls to 17.8±2.6 mmoll - 1 (p<0.05 vs vanadate-treated 
diabetics). I n non-diabetic rats (n = 8), vanadate signi-
ficantly reduced food intake to 33±1 g rat- 1 day-1 (p<0.05 
vs untreated non-diabetics) but did not significantly affect 
blood glucose (7.7±1.1 mmoll- 1 vs 9.1 ±0.6 mmoll-1 in 
untreated non diabetics; p>0.05). 
The glucose-lowering effect of vanadate in STZ-DM rats is 
therefore due entirely to its suppression of feeding. It may 
have no specific anti-diabetic action in vivo. 
P40. Diabetes in the elderly: a population 
based cohort study on the effect of glucose 
tolerance on mortality. 
Price D. E., Croxson S. C. M., Burden M. L., Jagger c., 
Boddington M., Burden A. C. Diabetes Research, 
Leicester General Hospital and Department of 
Community Health, Leicester University. 
Many consider the effect of diabetes in the elderly is mild: 
we have examined how mild. We determined the mortality 
of the Melton Mowbray cohort that we have studied 
previously. Melton residents aged 65, 70, 75, 80 or 85 yr on 
1.8.87 were screened using a 2 h plasma glucose post 75 g 
oral glucose. If the glucose was more than 11 mmoll-1 the 
test was repeated. The population was divided into known 
diabetics (n = 52), discovered diabetics (n = 18), impaired 
glucose tolerance, (IGT, n=44), normal glucose tolerance 
(n = 520) and refused (n = 191). Death certification was 
obtained from the Office of Population Census and Survey 
and from General Practitioners. After 53 months 11 % of 
normals, 52% of known diabetics, 39% of discovered 
diabetics, 20% of those with IGT and 18% of refusals had 
died. Using Cox's proportional hazards regressional model, 
with age and sex as strata, the relative risk (RR) of death (95% 
confidence intervals), compared with normals was 4.5 
(2.9-7.0) in all diabetics, 5.2 (3 .2-8.5) in known diabetics, 3.0 
(1.3-6.6) in discovered diabetics, 1.7 (0.8-3.5) in IGT and 1.5 
(1.0-2.4) in refusals. The known diabetics had a significantly 
higher mortality than discovered diabetics. (RR 1.8 (1.2-2.6)). 
In the elderly known diabetes and diabetes discovered by 
screening conSiderably increase mortality. 
P41. A District Diabetes Register is feasible: 
more patients than expected. 
Young R. J., Burns E., McDowall D., Davenport R. 
Diabetes and Endocrine Unit, Hope Hospital and 
Medical Audit Advisory Group, Salford. 
Audit is a tool for ensuring the comprehensiveness and 
quality of health care delivery. The impact of diabetes and 
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its complications can be reduced by well organized, 
integrated care and many important outcome measures are 
well recognized. But diabetes health care audit is a daunting 
task because the patient population is very large and widely 
dispersed between and within different levels of care. Thus, 
establishing a population based District Diabetes Register 
seems an inescapable prerequisite for successful audit. 
Salford district has a resident population of 228 205 (very few 
from ethnic minorities). All of the 125 GPs (66 practices) and 
the three Consultants (two physicians, one paediatrician) 
with an interest in diabetes are participating in a District 
Diabetes Audit project. The demographic details of all 
known diabetic patients have now been registered: 4950 
patients (M 49%, F 51 %) have been identified representing 
2.2% of the population, a higher proportion than anticipated; 
the interpractice variation in proportion of patients with 
identified diabetes was appreciable, 1-2.5%; more than half 
were 40-69 years 0Id-<19 (5.6%), 20-39 (9.6%),40-59 (28%), 
60-69 (24.6%), 70+ (32.2%); 54.2% (29-88) attend hospital, 
45.8% (18-71) wholly managed in primary care. In conclusion, 
establishing a District Diabetes Register is feasible; there is 
a high prevalence of diabetes in this urban district. 
P42. Spatial clustering in childhood onset 
diabetes during epidemic years: further 
evidence of an environmental cause. 
Bodington M., Burden A. C. Diabetes Care 
Department, Leicester General Hospital. 
We have previously presented evidence in favour of an 
environmental cause for Type 1 diabetes: it includes a major 
increase in the incidence of the disease with time; a 
changing incidence rate on migration; and epidemic peaks 
of incidence. We have now examined a case-control study 
comparing primary schools attended in an epidemic year 
(1986), compared with a non-epidemic year (1990). Our 
hypothesis: if environmental factors are important, primary 
schooling would be more likely to be shared by cases in an 
epidemic year compared with controls. Cases were 
identified from an established register with known accurate 
ascertainment; matched controls from age-sex-race-date of 
birth matched central register of all children (nearest 4); 
parents were asked to fill out a structured questionnaire on 
schooling. In 1986, 9 out of 29 cases clustered in primary 
schooling; 2 of 25 matched controls (4 non-responders), 
second matched controls 0 of 25 (4 non-responders). This 
was significantly different (95% confidence limit 0.03 to 0.43, 
p<0.05). There was no Significant difference in the non-
epidemic year. 
Temporo-spatial clustering occurs in Type 1 diabetes. The 
environmental factor should be sought during epidemic 
years, possibly related to schooling, though the vector is 
unknown. 
P43. Smoking is associated with reduced total 
plasma antioxidant activity in diabetes. 
Britton M. E., Chin L., Lewis G., Wickens D., Yudkin J. S. 
Academic Unit of Diabetes and Endocrinology and 
The Department of Chemical Pathology, Whittington 
Hospital, London. 
Free radical attack may damage macromolecules and 
contribute to the complications of diabetes. Smoking is a 
risk factor for the development of diabetic complications 
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